Financial statements Bioclar Polska
Balance sheet data of BIOCLAR POLSKA
|
Year
|
2018
|
2019
|
2020
|
2021
|
|---|---|---|---|---|
| Total assets | 133 775,37 | 1 146 377,11 | 1 363 945,04 | 1 564 729,31 |
| A. Fixed assets | 132 353,33 | 132 353,33 | 132 353,33 | 190 561,66 |
| B. Current assets | 1 422,04 | 1 014 023,78 | 1 231 591,71 | 1 374 167,65 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 133 775,37 | 1 146 377,11 | 1 363 945,04 | 1 564 729,31 |
| A. Equity | -412 096,43 | 247 782,61 | 441 832,10 | 650 670,69 |
| B. Liabilities and provisions for liabilities | 545 871,80 | 898 594,50 | 922 112,94 | 914 058,62 |
| I. Long-term liabilities | 541 743,38 | 541 743,38 | 541 743,38 | 541 743,38 |
| II. Short-term liabilities | 4 128,42 | 356 851,12 | 380 369,56 | 372 315,24 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.